HIMSS18: 3 trends to improve interoperability

Nicholas Leider | | Health Exec | Precision Medicine

Thousands of professionals are touching down in Las Vegas for the 2018 Healthcare Information and Management Systems Society (HIMSS) conference. To help prep visitors, Brian Mack, manager of marketing and communications for Great Lakes Health Connect, discusses three trends in interoperability on the HIMSS website. 

He breaks down the exchange of health information in different scales—local, regional and national. 

"Real interoperability is about recognizing the actual needs of the provider community, stepping out from behind the technology, and partnering to help them assist their patients achieve and maintain optimal health," Mack wrote. "This is an exciting time for health IT and health information exchange in particular. What is a guarantee is that interoperability will not look the same at the end of 2018 as it did at the start."

Read the full article below:

#empowerhit: Health Information Exchange — Progress Toward Achieving Interopera…

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.